αAzithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic fatal lung disease without a cure and new drug strategies are urgently needed. Differences in behavior between diseased and healthy cells are well known and drug response can be different between cells isolated from IPF patients and contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Krempaska, Kristina, Barnowski, Sandra, Gavini, Jacopo, Hobi, Nina, Ebener, Simone, Simillion, Cedric, Stokes, Andrea, Schliep, Ronja, Knudsen, Lars, Geiser, Thomas K., Funke-Chambour, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964061/
https://www.ncbi.nlm.nih.gov/pubmed/31941499
http://dx.doi.org/10.1186/s12931-020-1275-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964061/
https://www.ncbi.nlm.nih.gov/pubmed/31941499
http://dx.doi.org/10.1186/s12931-020-1275-8

Ejemplares similares